Hideko Murooka

824 total citations
9 papers, 372 citations indexed

About

Hideko Murooka is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Hideko Murooka has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Hideko Murooka's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Bone health and treatments (2 papers) and HER2/EGFR in Cancer Research (2 papers). Hideko Murooka is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Bone health and treatments (2 papers) and HER2/EGFR in Cancer Research (2 papers). Hideko Murooka collaborates with scholars based in Japan. Hideko Murooka's co-authors include Kazuo Kubo, Yoshiko Kobayashi, Toshiyuki Isoe, Hiroaki Ohno, Toshiyuki Shimizu, Tsuyoshi Nishitoba, Kazuhide Nakamura, Shinichiro Kato, Toshio Izawa and Kazumasa Hasegawa and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Immunology and Molecular Cancer Therapeutics.

In The Last Decade

Hideko Murooka

9 papers receiving 352 citations

Peers

Countries citing papers authored by Hideko Murooka

Since Specialization

Citations

This map shows the geographic impact of Hideko Murooka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideko Murooka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideko Murooka more than expected).

Fields of papers citing papers by Hideko Murooka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideko Murooka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideko Murooka. The network helps show where Hideko Murooka may publish in the future.

Co-authorship network of co-authors of Hideko Murooka

This figure shows the co-authorship network connecting the top 25 collaborators of Hideko Murooka. A scholar is included among the top collaborators of Hideko Murooka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideko Murooka. Hideko Murooka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis 2008 ·Journal of Neuroimmunology ·(unknown), Hiroaki Ohno, (unknown), (unknown), Hideko Murooka, Kazuo Kubo, (unknown)	29
2	The orally‐active and selective c‐Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen‐induced arthritis mouse model 2007 ·European Journal of Immunology ·Hiroaki Ohno, (unknown), Hideko Murooka, (unknown), (unknown), (unknown), Kazuo Kubo, (unknown)	55
3	A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model 2006 ·Molecular Cancer Therapeutics ·Hiroaki Ohno, Kazuo Kubo, Hideko Murooka, Yoshiko Kobayashi, Tsuyoshi Nishitoba, Masabumi Shibuya, Toshiyuki Yoneda, Toshiyuki Isoe	80
4	Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of N-Phenyl-N‘-{4-(4-quinolyloxy)phenyl}ureas 2005 ·Journal of Medicinal Chemistry ·Kazuo Kubo, Toshiyuki Shimizu, (unknown), Hideko Murooka, (unknown), Kazuhide Nakamura, Kazumasa Hasegawa, Yoshiko Kobayashi, Noriko Takahashi, Kazumi Takahashi, Shinichiro Kato, Toshio Izawa, Toshiyuki Isoe	131
5	Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Toshiyuki Shimizu, (unknown), Tatsushi Osawa, Teruyuki Sakai, Kin‐ya Kubo, Kazuo Kubo, Tsuyoshi Nishitoba, Kaname Kimura, (unknown), Hideko Murooka, (unknown), (unknown), (unknown), Atsushi Miwa	22
6	Synthesis and structure–activity relationship for new series of 4-Phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase 2003 ·Bioorganic & Medicinal Chemistry ·Kazuo Kubo, (unknown), Toshiyuki Shimizu, (unknown), Hideko Murooka, Tsuyoshi Nishitoba, Shinichiro Kato, Mikio Yagi, Yoshiko Kobayashi, (unknown), Toshiyuki Isoe, Kazuhide Nakamura, Hiroshi Iijima, Tatsushi Osawa, Toshio Izawa	19
7	Synthesis and structure-activity relationship of Quinazoline-Urea derivatives as novel orally active VEGF receptor tyrosine kinase selective inhibitors 2002 ·Kazuo Kubo, Yutaka Fujiwara, (unknown), Hideko Murooka, (unknown), Kazuhide Nakamura, Koki Hasegawa, Yoshiko Kobayashi, Naoko Takahashi, Kohei Takahashi, Masabumi Shibuya, (unknown), Toshiyuki Isoe	1
8	Beneficial Effects of a Novel Inhibitor of Platelet-Derived Growth Factor Receptor Autophosphorylation in the Rat with Mesangial Proliferative Glomerulonephritis 1998 ·General Pharmacology The Vascular System ·Mikio Yagi, Shinichiro Kato, Yoshiko Kobayashi, (unknown), (unknown), Kazuhide Nakamura, Kazuo Kubo, (unknown), Hideko Murooka, Toshiyuki Shimizu, Tsuyoshi Nishitoba, Tatsushi Osawa, Nobuo Nagano	19
9	A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylation 1997 ·Bioorganic & Medicinal Chemistry Letters ·Kazuo Kubo, Toshiyuki Shimizu, (unknown), Hideko Murooka, Tsuyoshi Nishitoba, Shinichiro Kato, Yoshiko Kobayashi, Mikio Yagi, Toshiyuki Isoe, Kazuhide Nakamura, Tatsushi Osawa, Toshio Izawa	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact